Monthly Archives: September 2020
In this case scenario, I explore some of the possible reasons that you may see a patient on duplicate SSRIs. A 68 year old female has a history of depression, breast cancer, diabetes, hypertension, and mild osteoarthritis. Current medications include: Fluoxetine 20 mg daily Dapagliflozin 10 mg daily Lantus 15 units at night Tamoxifen 20 […]
Read More
In this scenario, I review how medications can increase the blood clot risk. A 66 year old female is taking the following medications. Aspirin 81 mg daily Lamotrigine 100 mg BID Apixaban 5 mg BID Acetaminophen 500 mg BID Pantoprazole 40 mg daily Baclofen 10 mg BID Metoprolol 25 mg BID Conjugated estrogens 0.625 mg […]
Read More
A 69-year-old female is concerned with hair loss. She states that she does not have a family history of this issue and believes that her medications might be to blame. Her primary provider does not feel as if the hair loss is due to a medical issue (i.e. hypothyroidism etc.). Current diagnoses include: GERD Peptic […]
Read More
The omeprazole escitalopram interaction is a relatively common one in clinical practice. Below, I outline a case scenario where this interaction may have caused some adverse effects from escitalopram. An 81-year-old female has a history of depression, GERD, hypertension, and osteoarthritis. Current medications include amlodipine 10 mg daily, hydrochlorothiazide 12.5 mg daily, escitalopram 20 mg […]
Read More
GLP-1 agonists are an effective medication in treating type 2 diabetes mellitus. GLP-1 agonists are a synthetic version of the body’s naturally occurring GLP-1. However, synthetic GLP-1 has the advantage of being resistant to DPP4 degradation. GLP-1 agonists have many actions in the body that make them effective at lowering A1C as well as providing […]
Read More